Arctos Medical

Arctos Medical Focuses on Developing New Technologies Based on Optogenetics to Treat Inherited Retinal Dystrophies (IRDs) and Other Diseases Involving the Loss of Photoreceptor Cells, Such as Age-Related Macular Degeneration (AMD). Inherited Retinal Dystrophies Affect More Than 2 Million People Worldwide, Often Leading to Complete Blindness, and Can Be Caused by Mutations in Over 100 Different Genes. Age-Related Macular Degeneration Is a Leading Cause of Vision Impairment, Affecting an Estimated 170 Million People Globally, with No Cure Currently Available.